CF
SRNE

Centaurus Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Centaurus Financial’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,255
Closed -$36K – 951
2022
Q4 		$36K Hold
40,255
– – ﹤0.01% 825
2022
Q3 		$63K Hold
40,255
– – 0.01% 838
2022
Q2 		$81K Hold
40,255
– – 0.01% 811
2022
Q1 		$94K Buy
40,255
+2,700
+7% +$8.42K 0.01% 873
2021
Q4 		$175K Buy
37,555
+8,020
+27% +$49.8K 0.01% 714
2021
Q3 		$225K Buy
29,535
+4,100
+16% +$34.8K 0.02% 619
2021
Q2 		$246K Hold
25,435
– – 0.02% 620
2021
Q1 		$210K Hold
25,435
– – 0.02% 588
2020
Q4 		$174K Hold
25,435
– – 0.02% 589
2020
Q3 		$284K Sell
25,435
-2,840
-10% -$26K 0.04% 382
2020
Q2 		$178K Buy
28,275
+275
+1% +$1.05K 0.03% 457
2020
Q1 		$52K Buy
28,000
+5,000
+22% +$14.4K 0.01% 510
2019
Q4 		$78K Buy
23,000
+5,000
+28% +$11.9K 0.01% 620
2019
Q3 		$39K Hold
18,000
– – 0.01% 443
2019
Q2 		$48K Hold
18,000
– – 0.01% 589
2019
Q1 		$86K Buy
+18,000
New +$47.2K 0.01% 542
2018
Q3 		– Sell
-3,000
Closed -$22K – 2198
2018
Q2 		$22K Buy
+3,000
New +$20.4K ﹤0.01% 1241

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Centaurus Financial's SRNE Position: Q1 2023 in Review

Centaurus Financial sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 40,255 shares — an estimated $36K sold.

Centaurus Financial first reported a position in SRNE in Q2 2018 and held it in 17 quarters. The position peaked at $284K in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Centaurus Financial reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Centaurus Financial sold 40,255 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $36K.
  • Centaurus Financial first reported a position in Sorrento Therapeutics, Inc. in Q2 2018 and held it in 17 quarters.
  • Centaurus Financial's Sorrento Therapeutics, Inc. position peaked at $284K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Centaurus Financial's 13F filing for Q1 2023, filed 18 May 2023.